ClinicalTrials.Veeva

Menu

Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients

M

Mahidol University

Status and phase

Completed
Phase 3

Conditions

Atopic Dermatitis

Treatments

Other: Holly Mangrove Shower Gel
Other: Placebo shower gel

Study type

Interventional

Funder types

Other

Identifiers

NCT02178215
Si479/2013

Details and patient eligibility

About

Atopic dermatitis is a chronic intermittent inflammatory skin disease. Currently, there are many cosmeceutical skin products in which their major action affects skin hydration and skin barrier function. In addition, there are some herbal medication remedies used for the treatment of skin diseases based on the knowledge of Thai traditional medicine. Patients with pruritic rash symptoms who attended the Center of Applied Thai Traditional Medicine, Siriraj Hospital, were prescribed the Holly Mangrove Shower Gel to use and on the follow-up appointment showed significant improvement. Nevertheless, the knowledge of using this herbal medication for treating pruritic skin rash so far has been categorized as folk wisdom and not been confirmed by any clinical-trial study on its efficacy and mechanism of action.

Research teams chose Holly Mangrove Shower Gel containing Acanthus ebracteatus Vahl to act as adjunctive for treating atopic dermatitis. Thus, for the purpose of studying the efficacy of Holly Mangrove Shower Gel containing Acanthus ebracteatus Vahl in improving the skin barrier function in atopic dermatitis.

Full description

The investigators team research with patients by separate patients into 2 groups and compare among each other. In the first group use placebo, the other group use Holly Mangrove Shower Gel. To compare outcomes, the investigators will measure transepidermal water loss, stratum corneum hydration, skin pH, sebum and wrinkles after using studied gel.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years old or above
  • Diagnosed as atopic dermatitis (Hanafin and Rajka criteria)
  • No active dermatitis within 2 weeks

Exclusion criteria

  • Pregnancy or lactation
  • Any other skin diseases on forearms

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

30 participants in 2 patient groups, including a placebo group

Placebo shower gel
Placebo Comparator group
Description:
•Wash forearm by prepared placebo shower gel twice a day
Treatment:
Other: Placebo shower gel
Holly Mangrove Shower Gel
Active Comparator group
Description:
•Wash forearm by Holly Mangrove Showver gel twice a day
Treatment:
Other: Holly Mangrove Shower Gel

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems